APA
Katakami N., Mita T., Yoshii H., Shiraiwa T., Yasuda T., Okada Y., Umayahara Y., Kaneto H., Osonoi T., Yamamoto T., Kuribayashi N., Maeda K., Yokoyama H., Kosugi K., Ohtoshi K., Hayashi I., Sumitani S., Tsugawa M., Ohashi M., Taki H., Nakamura T., Kawashima S., Sato Y., Watada H. & Shimomura I. (2017). Rationale, Design, and Baseline Characteristics of the Utopia Trial for Preventing Diabetic Atherosclerosis Using an SGLT2 Inhibitor: A Prospective, Randomized, Open-Label, Parallel-Group Comparative Study. : Diabetes therapy : research, treatment and education of diabetes and related disorders.
Chicago
Katakami Naoto, Mita Tomoya, Yoshii Hidenori, Shiraiwa Toshihiko, Yasuda Tetsuyuki, Okada Yosuke, Umayahara Yutaka, Kaneto Hideaki, Osonoi Takeshi, Yamamoto Tsunehiko, Kuribayashi Nobuichi, Maeda Kazuhisa, Yokoyama Hiroki, Kosugi Keisuke, Ohtoshi Kentaro, Hayashi Isao, Sumitani Satoru, Tsugawa Mamiko, Ohashi Makoto, Taki Hideki, Nakamura Tadashi, Kawashima Satoshi, Sato Yasunori, Watada Hirotaka and Shimomura Iichiro. 2017. Rationale, Design, and Baseline Characteristics of the Utopia Trial for Preventing Diabetic Atherosclerosis Using an SGLT2 Inhibitor: A Prospective, Randomized, Open-Label, Parallel-Group Comparative Study. : Diabetes therapy : research, treatment and education of diabetes and related disorders.
Harvard
Katakami N., Mita T., Yoshii H., Shiraiwa T., Yasuda T., Okada Y., Umayahara Y., Kaneto H., Osonoi T., Yamamoto T., Kuribayashi N., Maeda K., Yokoyama H., Kosugi K., Ohtoshi K., Hayashi I., Sumitani S., Tsugawa M., Ohashi M., Taki H., Nakamura T., Kawashima S., Sato Y., Watada H. and Shimomura I. (2017). Rationale, Design, and Baseline Characteristics of the Utopia Trial for Preventing Diabetic Atherosclerosis Using an SGLT2 Inhibitor: A Prospective, Randomized, Open-Label, Parallel-Group Comparative Study. : Diabetes therapy : research, treatment and education of diabetes and related disorders.
MLA
Katakami Naoto, Mita Tomoya, Yoshii Hidenori, Shiraiwa Toshihiko, Yasuda Tetsuyuki, Okada Yosuke, Umayahara Yutaka, Kaneto Hideaki, Osonoi Takeshi, Yamamoto Tsunehiko, Kuribayashi Nobuichi, Maeda Kazuhisa, Yokoyama Hiroki, Kosugi Keisuke, Ohtoshi Kentaro, Hayashi Isao, Sumitani Satoru, Tsugawa Mamiko, Ohashi Makoto, Taki Hideki, Nakamura Tadashi, Kawashima Satoshi, Sato Yasunori, Watada Hirotaka and Shimomura Iichiro. Rationale, Design, and Baseline Characteristics of the Utopia Trial for Preventing Diabetic Atherosclerosis Using an SGLT2 Inhibitor: A Prospective, Randomized, Open-Label, Parallel-Group Comparative Study. : Diabetes therapy : research, treatment and education of diabetes and related disorders. 2017.